LW
Li Watsek Cantor Fitzgerald Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
14
Avg Return
Past Year
Past Year
23%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Financials
Asset Management
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $37 |
109%
upside
| 2 | -23% |
0
%
| 27 Feb ‘26 3 months ago |
|
|
|
Overweight
Initiated
| – | – | 1 | +12% |
0
%
| 24 Feb ‘26 3 months ago |
|
|
|
Overweight
Initiated
| – | – | 1 | +10% |
0
%
| 23 Dec ‘25 5 months ago |
|
|
|
Overweight
Initiated
| – | – | 1 | +4.6% |
0
%
| 3 Dec ‘25 6 months ago |
|
|
|
Overweight
Maintained
| $254 |
14%
upside
| 3 | +15% |
0
%
| 13 Oct ‘25 8 months ago |
|
|
|
Overweight
Initiated
| – | – | 1 | +236% |
0
%
| 2 Oct ‘25 8 months ago |
|
|
|
Overweight
Reiterated
| – | – | 1 | +48% |
0
%
| 9 Sep ‘25 9 months ago |
|
|
|
Overweight
Upgraded
| – | – | 2 | +17% |
0
%
| 30 Jul ‘25 10 months ago |
|
|
|
Overweight
Reiterated
| – | – | 1 | +50% |
0
%
| 26 Jun ‘25 11 months ago |
|